Favipiravir
Cost Effective Process Technology of Favipiravir Developed by CSIR Used by M/s Cipla Ltd.
Jul 24, 2020 11:00 IST
1 Min read
Glenmark Announces Results of Phase 3 Clinical Trial of Favipiravir on COVID Patients
Jul 23, 2020 05:33 IST
3 Min read
Glenmark’s Favipiravir is Different from Livealth Bio Pharma’s Livfavir
Jun 25, 2020 09:45 IST
2 Min read
COVID-19 Drug By Glenmark Set for Market at Rs 103 Per Tablet After Getting DCGI Approval
Jun 20, 2020 15:22 IST
3 Min read
Glenmark: Antiviral Favipiravir To Enter into Phase 3 of Clinical Trials
May 26, 2020 05:53 IST
1 Min read